Published on: 1 June 2023
The 2021 ALERTT1 trial concluded that switching from intermittently-scanned continuous glucose monitoring (isCGM) to real-time CGM (rtCGM) significantly improved time in range (TIR), A1C, and time in hypoglycemia for adults...
Clinical Evidence